CI-581a for alcoholism

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 10 Sep 2019: Trial registered, NCT04084860
  2. 8 Nov 2019: Trial started, NCT04084860

The trials

NCT04084860: The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking

State
Under way
Phase
Phase 2
People
120 planned
Started
8 Nov 2019
Primary completion
31 Aug 2024
Arms
CI-581a + MET/MBRP, CI-581a + Medication Management
Results
None posted
  1. 10 Sep 2019: Trial registered
  2. 8 Nov 2019: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.